Outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients

Journal of Critical Care

Volumn 29, Issue 3, 2014, Pages 356-361

  Ko, Yousang ^a,b   Jeong, Byeong Ho ^a   Park, Hye Yun ^a   Koh, Won Jung ^a   Suh, Gee Young ^a   Chung, Man Pyo ^a   Kwon, O Jung ^a   Jeon, Kyeongman ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Neoplasms; Outcomes; Pneumocystis pneumonias; Respiratory insufficiency

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; PENTAMIDINE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CAUSE OF DEATH; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PNEUMOCYSTIS PNEUMONIA; PNEUMOTHORAX; PREDICTION; PROGNOSIS; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SHOCK; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT RESPONSE; VENTILATOR ASSOCIATED PNEUMONIA; COMPLICATION; MIDDLE AGED; NEOPLASM; ORGAN TRANSPLANTATION; PNEUMONIA, PNEUMOCYSTIS; REGRESSION ANALYSIS; RESPIRATORY INSUFFICIENCY; SERODIAGNOSIS; SEVERITY OF ILLNESS INDEX;

ACUTE KIDNEY INJURY; AGED; FEMALE; HIV SERONEGATIVITY; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEOPLASMS; ORGAN TRANSPLANTATION; PNEUMONIA, PNEUMOCYSTIS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROGNOSIS; REGRESSION ANALYSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHOCK;

EID: 84899984561     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.12.005     Document Type: Article

References (33)

1. Montgomery A.B. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention. Semin Respir Infect 1989, 4:102-110.
2. Thomas C.F., Limper A.H. Pneumocystis pneumonia. N Engl J Med 2004, 350:2487-2498.
3. Gilroy S.A., Bennett N.J. Pneumocystis pneumonia. Semin Respir Crit Care Med 2011, 32:775-782.
4. Curtis J.R., Yarnold P.R., Schwartz D.N., et al. Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 2000, 162:393-398.
5. Morris A., Wachter R.M., Luce J., et al. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003, 17:73-80.
6. Miller R.F., Allen E., Copas A., et al. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax 2006, 61:716-721.
7. Sepkowitz K.A., Brown A.E., Telzak E.E., et al. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992, 267:832-837.
8. Arend S.M., Kroon F.P., van't Wout J.W. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med 1995, 155:2436-2441.
9. Yale S.H., Limper A.H. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996, 71:5-13.
10. Roblot F., Godet C., Le Moal G., et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002, 21:523-531.
11. Matsumura Y., Shindo Y., Iinuma Y., et al. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis 2011, 11:76.
12. Reid A.B., Chen S.C., Worth L.J. Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis 2011, 24:534-544.
13. Thomas C.F., Limper A.H. Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome. Semin Respir Infect 1998, 13:289-295.
14. Tasaka S., Tokuda H. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother 2012, 18(6):793-806.
15. Limper A.H., Offord K.P., Smith T.F., et al. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989, 140:1204-1209.
16. Monnet X., Vidal-Petiot E., Osman D., et al. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care 2008, 12:R28.
17. Boonsarngsuk V., Sirilak S., Kiatboonsri S. Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors. Int J Infect Dis 2009, 13:59-66.
18. Lam W.Y., Yeung A.C., Tang J.W., et al. Rapid multiplex nested PCR for detection of respiratory viruses. J Clin Microbiol 2007, 45:3631-3640.
19. Costa C., Delsedime L., Solidoro P., et al. Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation. Transplant Proc 2010, 42:1270-1274.
20. Moreno R.P., Metnitz P.G., Almeida E., et al. SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005, 31:1345-1355.
21. Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
22. Walmsley S., Levinton C., Brunton J., et al. A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:348-357.
23. Smego R.A., Nagar S., Maloba B., et al. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch Intern Med 2001, 161:1529-1533.
24. Limper A.H., Knox K.S., Sarosi G.A., et al. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2011, 183:96-128.
25. Saah A.J., Hoover D.R., Peng Y., et al. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. JAMA 1995, 273:1197-1202.
26. Mickey R.M., Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989, 129:125-137.
27. Mansharamani N.G., Garland R., Delaney D., et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000, 118:704-711.
28. Festic E., Gajic O., Limper A.H., et al. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest 2005, 128:573-579.
29. Sepkowitz K.A. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002, 34:1098-1107.
30. Pareja J.G., Garland R., Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998, 113:1215-1224.
31. Montgomery A.B., Stager M.A., Carrico C.J., et al. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985, 132:485-489.
32. Stapleton R.D., Wang B.M., Hudson L.D., et al. Causes and timing of death in patients with ARDS. Chest 2005, 128:525-532.
33. Song J.U., Suh G.Y., Park H.Y., et al. Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units. Intensive Care Med 2012, 38:1505-1513.